Immunobiological effects of tocilizumab across respiratory subphenotypes in COVID-19 ARDS.
Saved in:
| Title: | Immunobiological effects of tocilizumab across respiratory subphenotypes in COVID-19 ARDS. |
|---|---|
| Authors: | Rademaker E; Department of Intensive Care Medicine, UMC Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands. e.rademaker-2@umcutrecht.nl.; Julius Center for Health Sciences and Primary Care, Utrecht University, Utrecht, The Netherlands. e.rademaker-2@umcutrecht.nl., Filippini DFL; Department of Intensive Care Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Haitsma Mulier JLG; Department of Intensive Care Medicine, UMC Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.; Julius Center for Health Sciences and Primary Care, Utrecht University, Utrecht, The Netherlands., Slim MA; Department of Intensive Care Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., van Amstel RBE; Department of Intensive Care Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Bhavani SV; Department of Medicine, Emory University, Atlanta, Georgia., Juffermans NP; Laboratory of Translational Intensive Care, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.; Department of Intensive Care, Erasmus Medical Center, Rotterdam, The Netherlands., de Grooth HS; Department of Intensive Care Medicine, UMC Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands., Derde LPG; Department of Intensive Care Medicine, UMC Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.; Julius Center for Health Sciences and Primary Care, Utrecht University, Utrecht, The Netherlands., Cremer OL; Department of Intensive Care Medicine, UMC Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands., Bos LDJ; Department of Intensive Care Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Department of Pulmonology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Laboratory of Experimental Intensive Care and Anaesthesiology (L.E.I.C.A.), University of Amsterdam, Amsterdam, The Netherlands. |
| Corporate Authors: | Amsterdam U. M. C. COVID-19 Biobank Study Group |
| Source: | Intensive care medicine experimental [Intensive Care Med Exp] 2025 Jul 09; Vol. 13 (1), pp. 70. Date of Electronic Publication: 2025 Jul 09. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer-Verlag, GmbH Country of Publication: Germany NLM ID: 101645149 Publication Model: Electronic Cited Medium: Print ISSN: 2197-425X (Print) Linking ISSN: 2197425X NLM ISO Abbreviation: Intensive Care Med Exp Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2197-425X |
|---|---|
| DOI: | 10.1186/s40635-025-00779-z |
